ALL vs DMAC · P/E 4.9, $56.89B cap vs $157.4M cap
The Allstate Corporation (ALL) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
DMAC does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the ALL and DMAC stock pages for the full models.
Not investment advice.